dalteparin has been researched along with Carcinoma, Squamous Cell in 8 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with oesophageal cancer undergoing neoadjuvant chemoradiotherapy and surgery are at substantial risk of thromboembolic and bleeding events throughout all stages of treatment." | 1.56 | Thromboembolic and bleeding complications in patients with oesophageal cancer. ( Büller, HR; Hovenkamp, A; Hulshof, MCCM; Kamphuisen, PW; Middeldorp, S; Mulder, FI; van Berge Henegouwen, MI; van Es, N; van Laarhoven, HWM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Mulder, FI | 1 |
| Hovenkamp, A | 1 |
| van Laarhoven, HWM | 1 |
| Büller, HR | 1 |
| Kamphuisen, PW | 1 |
| Hulshof, MCCM | 1 |
| van Berge Henegouwen, MI | 1 |
| Middeldorp, S | 1 |
| van Es, N | 1 |
| Groen, HJM | 1 |
| van der Heijden, EHFM | 1 |
| Klinkenberg, TJ | 1 |
| Biesma, B | 1 |
| Aerts, J | 1 |
| Verhagen, A | 1 |
| Kloosterziel, C | 1 |
| Pieterman, R | 1 |
| van den Borne, B | 1 |
| Smit, HJM | 1 |
| Hoekstra, O | 1 |
| Schramel, FMNH | 1 |
| van der Noort, V | 1 |
| van Tinteren, H | 1 |
| Smit, EF | 1 |
| Dingemans, AC | 1 |
| Carmazzi, Y | 1 |
| Iorio, M | 1 |
| Armani, C | 1 |
| Cianchetti, S | 1 |
| Raggi, F | 1 |
| Neri, T | 1 |
| Cordazzo, C | 1 |
| Petrini, S | 1 |
| Vanacore, R | 1 |
| Bogazzi, F | 1 |
| Paggiaro, P | 1 |
| Celi, A | 1 |
| Patel, N | 1 |
| Singhal, D | 1 |
| Brown, TJ | 1 |
| Khan, SA | 1 |
| Lui, JK | 1 |
| McIntosh, LJ | 1 |
| Escobar Valle, J | 1 |
| Stockl, T | 1 |
| Summers, S | 1 |
| Cunningham, MS | 1 |
| Gilmore, R | 1 |
| O'Donnell, D | 1 |
| O'Donnell, JS | 2 |
| Byrne, M | 2 |
| Reynolds, JV | 1 |
| Keogan, M | 1 |
| White, B | 1 |
| Murphy, S | 1 |
| Maher, SG | 1 |
| Pidgeon, GP | 1 |
1 trial available for dalteparin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung | 2019 |
7 other studies available for dalteparin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Thromboembolic and bleeding complications in patients with oesophageal cancer.
Topics: Adenocarcinoma; Aged; Anticoagulants; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; E | 2020 |
The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines.
Topics: Adenocarcinoma; Anticoagulants; Apoptosis; Carcinoma, Squamous Cell; cdc25 Phosphatases; Cell Cycle | 2012 |
Activated clotting time monitoring during osteocutaneous free fibula flap surgery.
Topics: Aged; Anticoagulants; Blood Coagulation; Carcinoma, Squamous Cell; Enoxaparin; Facial Neoplasms; Fem | 2015 |
Large saddle embolus during cancer therapy.
Topics: Aged; Anticoagulants; Carcinoma, Squamous Cell; Chemoradiotherapy; Enoxaparin; Humans; Male; Pulmona | 2016 |
Facial Drooping, Aphasia, and an Incidental Lung Mass in a Nonsmoker.
Topics: Aged; Air Pollutants, Occupational; Anticoagulants; Aphasia; Atrial Flutter; Carcinoma, Squamous Cel | 2017 |
Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen.
Topics: Adult; Carcinoma, Squamous Cell; Enoxaparin; Female; Fibrinolytic Agents; Humans; International Norm | 2009 |
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery.
Topics: Adenocarcinoma; Adult; Aged; Anticoagulants; Biomarkers; Carcinoma, Squamous Cell; Combined Modality | 2010 |